Affirm
AFRM
$74.88
+0.17%
Affirm Holdings is a leading buy-now-pay-later (BNPL) platform operating in the Financial Services sector, offering point-of-sale installment financing through both merchant-subsidized zero-interest plans and interest-bearing personal loans approved on a per-transaction basis. With roughly $36 billion in transaction volume in fiscal 2025 and over 70% of that volume coming from interest-bearing loans, Affirm has established itself as a market leader in the BNPL space, distinct for its transparent underwriting model and deep merchant network integrations. The current investor narrative centers on the company's dramatic profitability inflection — Q4 FY2026 delivered a massive earnings beat driven by strong GMV growth and rising adoption of the Affirm Card, with net income surging to $1.62 billion (boosted by a one-time tax benefit). However, debate persists around whether this profitability is sustainable given the company's high beta, elevated debt levels, and the inherent credit risk in its consumer lending book, especially as the stock has underperformed the broader market over the past year despite recent operational wins.…
AFRM
Affirm
$74.88
Related headlines
Investment Opinion: Should I buy AFRM Today?
Based on the synthesized data, Affirm Holdings (AFRM) earns a Buy rating for investors with a high risk tolerance and a long-term horizon. The core thesis is that Affirm is a market leader in BNPL with a proven ability to grow revenue at 24% YoY while expanding margins, and the recent selloff has created an attractive entry point with 40% upside to the analyst average target of $99.09. The consensus analyst recommendation is 'Buy' (mean 1.59), and the forward PE of 14.66x is undemanding relative to growth, suggesting the market is undervaluing the earnings trajectory.
Supporting evidence includes: (1) Revenue growth of 24.33% YoY in Q4 FY2026, with sequential gains from $933M to $1.09B; (2) Gross margin of 69.4% and operating margin of 24.3%, up from 6.6% a year ago, demonstrating operating leverage; (3) Free cash flow of $993 million TTM, providing financial flexibility; (4) A forward PE of 14.66x and PS ratio of 6.92x, which, while at a premium to traditional lenders, is justified by superior growth and technology platform characteristics. The implied upside to the average analyst target is ~40%, and the PEG ratio, though distorted, suggests undervaluation relative to growth.
However, the rating is not without caveats. The biggest risks are: (1) The sustainability of profitability excluding the $1.45 billion tax benefit—underlying pre-tax income was only $169.1 million; (2) The extreme volatility (beta 3.61) and potential for severe drawdowns; (3) Credit risk in the consumer loan book, which could deteriorate if the economy weakens. The rating would upgrade to a strong buy if Affirm demonstrates consistent pre-tax earnings growth above $200 million per quarter and maintains credit quality. It would downgrade to Hold if revenue growth decelerates below 15% or if credit losses rise significantly. Relative to its history and peers, AFRM appears undervalued on a growth-adjusted basis, but the premium PS multiple means it is not a deep-value play.
Sign up to view all
AFRM 12-Month Price Forecast
Affirm presents a compelling growth story with a recent profitability inflection that has yet to be fully reflected in the valuation. The forward PE of 14.66x is undemanding for a company growing revenue at 24% and expanding margins, and the analyst consensus target of $99.09 implies significant upside. However, the sustainability of earnings excluding the one-time tax benefit, the extreme beta of 3.61, and credit risk in the loan book warrant caution. The base case (50% probability) assumes moderate growth and stable margins, leading to a target range of $90-105. I would upgrade to high confidence if Affirm reports another quarter of strong pre-tax earnings and maintains credit quality; I would downgrade to neutral if revenue growth falls below 15% or if credit losses rise materially.
Wall Street consensus
Most Wall Street analysts maintain a constructive view on Affirm's 12-month outlook, with a consensus price target around $98.66 and implied upside of +31.8% versus the current price.
Average Target
$98.66
0 analysts
Implied Upside
+31.8%
vs. current price
Analyst Count
—
covering this stock
Price Range
$66 - $115
Analyst target range
Affirm is covered by 32 analysts, indicating robust institutional interest for a mid-cap financial technology company. The consensus recommendation is "Buy" with a recommendation mean of 1.59 (on a scale where 1 = Strong Buy and 5 = Strong Sell), reflecting a strongly bullish analyst community. The average target price is $99.09, which implies approximately +40.0% upside from the current price of $70.77 — a substantial projected return that suggests analysts believe the recent selloff represents a significant buying opportunity. The consensus leans decidedly bullish, with the vast majority of recent ratings being Buy or Outperform equivalents, including Goldman Sachs (Buy), JP Morgan (Overweight), Bernstein (Outperform), and TD Cowen (Buy), all reaffirmed in late August and early September 2026. The target price range spans from a low of $66.00 to a high of $124.00, representing a spread of $58.00 — or approximately 88% of the low target — which signals considerable disagreement among analysts about the company's trajectory. The high target of $124.00 implies roughly +75% upside and would require either significant multiple expansion (forward PE expanding from 14.66x to ~22x) or substantially higher earnings than the current consensus estimate of $5.56 per share, potentially driven by accelerating Affirm Card adoption, international expansion success, or new merchant partnerships. The low target of $66.00, which is actually below the current price of $70.77 (implying -6.7% downside), prices in concerns about credit quality deterioration in the consumer lending book, margin compression from rising funding costs, or competitive pressures from other BNPL providers and traditional credit card issuers. The institutional ratings pattern shows a notable upgrade from Wolfe Research (Peer Perform to Outperform on September 14, 2026) and consistent reaffirmations from major firms, suggesting analysts are becoming more constructive rather than less. The estimated revenue average of $11.35 billion for the next fiscal year (range: $10.62B to $12.15B) implies approximately 15-20% growth from current run-rate levels, while the estimated EPS range of $5.09 to $6.07 reflects uncertainty around the sustainability of recent margin improvements. The wide target spread, combined with the stock's beta of 3.61 and short ratio of 2.88, indicates that while analyst sentiment is bullish, the market is pricing in significant uncertainty — creating potential for sharp moves in either direction as new information emerges.
Bulls vs Bears: AFRM Investment Factors
The bull case for Affirm rests on its impressive revenue growth (24.3% YoY), dramatic profitability inflection (operating margin up to 24.3%), strong free cash flow ($993M TTM), and a consensus analyst target implying 40% upside. However, the bear case highlights significant risks: extreme volatility (beta 3.61), a tax-benefit-distorted earnings picture, elevated debt (D/E 1.79), and recent underperformance versus the market. Currently, the bull evidence appears stronger, given the operational momentum and analyst optimism, but the single most important tension is whether the profitability improvement is sustainable without the one-time tax benefit and amid credit risk. If Affirm can demonstrate consistent pre-tax earnings growth and maintain credit quality, the stock could re-rate higher; conversely, any deterioration in credit metrics or margin compression could trigger a sharp selloff given the high beta.
Bullish
- Revenue growth remains robust at 24.3% YoY: Q4 FY2026 revenue reached $1.09 billion, up 24.33% from $876 million in Q4 FY2025, with sequential growth from $933M in Q1 to $1.04B in Q3 and $1.09B in Q4. This consistent double-digit expansion demonstrates durable demand for Affirm's BNPL offerings and successful scaling of the Affirm Card and merchant network.
- Profitability inflection with operating margin expansion: Operating margin surged to 24.3% in Q4 FY2026 from just 6.6% a year earlier, while gross margin improved to 69.4% from 65.9% in Q3. Excluding the one-time $1.45 billion tax benefit, pre-tax income was $169.1 million, yielding a ~15.5% net margin—a dramatic turnaround from near-breakeven levels in FY2025.
- Strong free cash flow generation and liquidity: Trailing twelve-month free cash flow stands at $993 million, with Q4 FCF of $229.5 million and Q3 FCF of $325.4 million. The company holds $2.43 billion in cash and has a current ratio of 12.73, providing ample liquidity to fund loan origination growth and weather economic downturns.
- Analyst consensus bullish with 40% upside: 32 analysts cover AFRM with a consensus 'Buy' rating (mean 1.59) and an average target price of $99.09, implying ~40% upside from the current $70.77. Recent reaffirmations from Goldman Sachs, JP Morgan, Bernstein, and TD Cowen, plus an upgrade from Wolfe Research, signal growing institutional confidence.
Bearish
- Extreme volatility with beta of 3.61: Affirm's beta of 3.61 means it is approximately 3.6 times more volatile than the broader market, exposing investors to severe drawdowns during market corrections. The stock's max drawdown of -53.86% over the past year underscores this risk, and position sizing must account for such amplified swings.
- Profitability distorted by one-time tax benefit: Q4 FY2026 net income of $1.62 billion was heavily inflated by a $1.45 billion income tax benefit; without it, pre-tax income was only $169.1 million. The reported net margin of 148.4% is an artifact, and the underlying ~15.5% net margin, while improved, may not be sustainable given ongoing credit and funding costs.
- Elevated debt and weak interest coverage: The debt-to-equity ratio of 1.79 is high for a lending business, and interest coverage of 2.24x indicates that debt servicing consumes a significant portion of earnings. The cash flow to debt ratio of just 0.030 highlights limited ability to repay debt from operating cash flow, increasing vulnerability to rising interest rates.
- Recent underperformance and negative momentum: Despite a 52.8% gain over six months, AFRM has declined 4.48% in the past month and 16.33% over three months, significantly underperforming the S&P 500's +0.59% and +3.34% respectively. This relative weakness (relative strength of -5.07 and -19.67) suggests waning investor confidence and potential trend reversal.
AFRM Technical Analysis
Affirm is in a broad recovery phase following a significant drawdown, with the stock currently trading at $70.77, representing a -8.60% decline over the past year but a remarkable +52.82% gain over the past six months. The current price sits at approximately 59.4% of its 52-week range (from a low of $42.10 to a high of $90.44), indicating the stock has recovered substantially from its lows but remains well below its peak — a positioning that suggests neither extreme overextension nor deep value, but rather a mid-cycle consolidation. The maximum drawdown of -53.86% underscores the severity of the prior selloff, and the recovery to the current level implies the market has regained confidence in the fundamental story. Recent momentum is concerning, however, with the stock down -4.48% over the past month and -16.33% over the past three months, diverging sharply from the positive six-month trend. This deceleration is particularly notable given that the S&P 500 (SPY) gained 0.59% over the past month and 3.34% over the past three months, resulting in relative strength readings of -5.07 and -19.67 respectively — meaning Affirm is significantly underperforming the market on a short-to-intermediate basis. The 1-month decline conflicting with the 6-month rally could signal either a healthy pullback within an uptrend or the early stages of a trend reversal, and the recent price action from the July high of $85.78 to the current $70.77 (-17.5%) suggests the market is repricing growth expectations. Key technical levels to monitor include support at the 52-week low of $42.10, with intermediate support likely around the $65-68 zone where the stock has found buyers in September, and resistance at the 52-week high of $90.44. A breakout above $90 would signal renewed bullish conviction and potentially open the door to new highs, while a breakdown below $65 could accelerate selling pressure toward the $50-55 area. The stock's beta of 3.61 is extraordinarily high — meaning Affirm is approximately 3.6 times more volatile than the broader market — which has profound implications for position sizing and risk management, as even modest market corrections could translate into severe drawdowns for AFRM holders.
Beta
3.82
3.82x market volatility
Max Drawdown
-53.9%
Largest decline past year
52-Week Range
$42-$90
Price range past year
Annual Return
-1.3%
Cumulative gain past year
| Period | AFRM Return | S&P 500 |
|---|---|---|
| 1m | +3.5% | +1.2% |
| 3m | -7.9% | +4.5% |
| 6m | +52.8% | +14.6% |
| 1y | -1.3% | +16.0% |
| ytd | +1.1% | +14.3% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
AFRM Fundamental Analysis
Affirm's revenue trajectory has been consistently strong, with Q4 FY2026 (ending June 30, 2026) revenue reaching $1.09 billion, representing 24.33% year-over-year growth from $876 million in Q4 FY2025. The multi-quarter trend shows steady sequential expansion: revenue grew from $933 million in Q1 FY2026 to $1.04 billion in Q3 and $1.09 billion in Q4, demonstrating sustained top-line momentum. The Merchant Network segment generated $302.4 million while the Virtual Card Network contributed $85.2 million, with the Affirm Card showing rising adoption as a key growth driver. This consistent double-digit growth rate, combined with the company's expansion into Canada and the UK, suggests the investment case remains anchored in volume-driven scaling rather than one-time gains. Profitability has inflected dramatically, with Q4 FY2026 net income of $1.62 billion — though this figure is heavily distorted by a $1.45 billion income tax benefit (negative tax expense), without which pre-tax income was $169.1 million. Gross margin stands at a healthy 69.4% in Q4, up from 65.9% in Q3 and 67.7% in Q4 FY2025, while operating margin reached 24.3% in Q4 compared to just 6.6% a year earlier. The net margin of 148.4% in Q4 is an artifact of the tax benefit; excluding it, the underlying net margin would be approximately 15.5% (pre-tax income of $169.1M on $1.09B revenue), which still represents a significant improvement from the near-breakeven levels seen in FY2025. The balance sheet presents a mixed picture: the debt-to-equity ratio of 1.79 is elevated but manageable for a lending business, and the current ratio of 12.73 reflects substantial short-term liquidity. However, the cash flow to debt ratio of just 0.030 and interest coverage of 2.24x indicate that debt servicing consumes a meaningful portion of earnings. Free cash flow on a trailing twelve-month basis is $993 million, with Q4 FCF of $229.5 million and Q3 FCF of $325.4 million, demonstrating the company's ability to generate cash internally. ROE of 35.2% is impressive, though partly inflated by the tax benefit, while ROA of just 1.93% reflects the capital-intensive nature of the lending model. The company holds $2.43 billion in cash as of Q4 FY2026, providing a solid liquidity buffer, but the reliance on debt financing (net cash from financing was $865.6 million in Q4) suggests external capital remains an important funding source for loan origination growth.
Quarterly Revenue
$1.1B
2026-06
Revenue YoY Growth
+24.3%
YoY Comparison
Gross Margin
69.4%
Latest Quarter
Free Cash Flow
$993090000.0B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Revenue Breakdown
Open an Account, get $2 TSLA now!
Valuation Analysis: Is AFRM Overvalued?
Given that Affirm's trailing net income is positive ($1.62 billion in Q4 FY2026, albeit tax-benefit-inflated), the PE ratio is the primary valuation metric, with a trailing PE of 14.16x and a forward PE of 14.66x. The near-identical trailing and forward PE ratios imply the market is not pricing in significant earnings growth over the next twelve months, which is unusual for a company growing revenue at 24% year-over-year — this disconnect likely reflects the market's skepticism about the sustainability of the tax-benefit-boosted earnings. On a price-to-sales basis, the PS ratio of 6.92x and EV/Sales of 7.53x provide a cleaner view of the company's valuation relative to its revenue base, while the EV/EBITDA of 27.78x suggests the market is paying a substantial premium for operating cash flows. The PEG ratio of 0.004 is anomalously low and likely distorted by the tax benefit, making it unreliable as a valuation signal. Compared to the broader Financial Services sector, Affirm's PS ratio of 6.92x represents a significant premium to typical credit services companies, which often trade at 2-4x sales. However, this premium is partially justified by Affirm's technology-platform characteristics, superior growth rate (24% YoY revenue growth vs. mid-single-digit for traditional lenders), and gross margin of 69.1% — far above the 40-50% typical for consumer finance companies. The PB ratio of 4.98x is also elevated relative to traditional banks (often 1-2x book), reflecting the market's assessment of Affirm's intangible assets, technology platform, and growth optionality. The forward PE of 14.66x against estimated EPS of $5.56 for the next fiscal year suggests that if the company can sustain its earnings trajectory, the stock is reasonably valued — but the wide gap between trailing GAAP EPS of $0.07 (as reported in key metrics) and the forward estimate of $5.56 highlights the enormous uncertainty in earnings projections. Historically, Affirm's valuation has compressed dramatically from its early years: the PS ratio was 120.1x in Q1 FY2022 and 78.4x in Q2 FY2022, declining to the current 6.92x — a massive de-rating that reflects the company's transition from hyper-growth story to profitability-focused business. The PE ratio history shows a similar pattern, with negative PE ratios through FY2023 and FY2024 before turning positive in FY2025 and compressing to the current 14.16x. This historical context suggests the stock is now valued more like a mature financial company than a high-growth tech platform, which could represent either a value opportunity (if growth persists) or a value trap (if growth decelerates further).
PE
14.2x
Latest Quarter
vs. Historical
Low-End
5-Year PE Range 4x~82x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
27.8x
Enterprise Value Multiple
Investment Risk Disclosure
Financial and operational risks are significant for Affirm. The debt-to-equity ratio of 1.79 is elevated for a consumer lender, and interest coverage of 2.24x means a substantial portion of earnings is consumed by debt servicing. The cash flow to debt ratio of just 0.030 indicates limited capacity to repay debt from operating cash flow, making the company reliant on continued access to capital markets. Additionally, the Q4 FY2026 net income of $1.62 billion was inflated by a $1.45 billion tax benefit; excluding it, pre-tax income was $169.1 million, highlighting that underlying profitability, while improving, remains modest relative to the balance sheet. Revenue concentration is another concern: over 95% of revenue comes from the United States, and more than 70% of transaction volume is from interest-bearing loans, exposing Affirm to U.S. consumer credit cycles and regulatory changes.
Market and competitive risks are pronounced. Affirm trades at a premium valuation with a PS ratio of 6.92x and EV/EBITDA of 27.78x, well above traditional credit services companies (often 2-4x sales). This premium leaves little room for error; any slowdown in growth or margin compression could lead to multiple compression. The stock's beta of 3.61 makes it highly sensitive to market downturns, and its recent underperformance (-16.33% over three months vs. S&P 500 +3.34%) suggests waning momentum. Competitive threats from other BNPL providers like Sezzle, Klarna, and traditional credit card issuers are intensifying, and regulatory scrutiny of the BNPL industry could increase compliance costs. Recent news highlights Sezzle's efficient marketing and subscriber growth, indicating a competitive landscape where Affirm must continuously invest to maintain its edge.
The worst-case scenario involves a U.S. consumer credit deterioration leading to higher loan losses, combined with rising funding costs and a market rotation away from high-beta growth stocks. In this scenario, Affirm's earnings could disappoint, and the stock could retest its 52-week low of $42.10, representing a -40.5% decline from the current price of $70.77. The analyst low target of $66 implies a more modest -6.7% downside, but given the stock's historical max drawdown of -53.86%, a more severe selloff is possible if credit conditions worsen. Investors could lose 40% or more in such an adverse scenario, emphasizing the need for careful risk management.
FAQ
The key risks include: (1) Financial risk: high debt-to-equity of 1.79 and weak interest coverage of 2.24x, with cash flow to debt of only 0.030, making it vulnerable to rising rates; (2) Credit risk: over 70% of volume is interest-bearing loans, and a consumer downturn could lead to higher loan losses; (3) Market risk: beta of 3.61 means the stock is highly volatile and can drop sharply in market corrections; (4) Competitive risk: intensifying competition from Klarna, Sezzle, and traditional lenders could pressure margins. The most severe risk is a credit cycle downturn, which could cause the stock to retest its 52-week low of $42.10.
Our 12-month forecast has three scenarios: Bull case (30% probability) targets $110-124, assuming revenue growth >20%, margin expansion, and multiple re-rating; Base case (50% probability) targets $90-105, assuming 15-20% revenue growth and stable margins, aligning with the analyst average target of $99.09; Bear case (20% probability) targets $42-66, assuming a consumer credit downturn and growth deceleration. The base case is most likely, hinging on Affirm maintaining its growth trajectory and delivering on earnings expectations. Key catalysts include Q1 FY2027 earnings and Affirm Card adoption.
AFRM appears undervalued on a growth-adjusted basis but carries a premium on absolute metrics. The forward PE of 14.66x is low for a company growing revenue at 24% YoY, and the PEG ratio, though distorted, suggests undervaluation. However, the PS ratio of 6.92x and EV/EBITDA of 27.78x are above traditional credit services peers (2-4x sales), reflecting a premium for its technology platform and growth. The market is pricing in skepticism about the sustainability of earnings, given the one-time tax benefit. If Affirm can deliver consistent pre-tax earnings, the multiple could expand, making the stock undervalued; if growth slows, the premium may compress.
From a risk/reward perspective, AFRM offers a potentially attractive opportunity for aggressive investors. The stock trades at $70.77, with a consensus analyst target of $99.09 implying ~40% upside, and a forward PE of 14.66x that is low relative to its 24% revenue growth. However, the downside risk is substantial: the 52-week low is $42.10, representing a -40.5% decline, and the beta of 3.61 means it can swing wildly. The biggest risk is credit deterioration in its loan book, which could lead to earnings misses. For investors with a high risk tolerance and a long-term horizon, AFRM can be a good buy, especially if it demonstrates sustainable profitability. Those seeking stability should avoid it.
AFRM is more suitable for long-term investment (minimum 3-5 years) due to its high volatility (beta 3.61) and the need for time to realize its growth potential. The company pays no dividend, so returns depend entirely on capital appreciation. Short-term trading is risky given the stock's sharp swings and recent negative momentum (-16.33% over three months). Long-term investors can benefit from the BNPL secular trend and Affirm's market leadership, but should be prepared for significant drawdowns. A suggested minimum holding period is 3 years to ride out credit cycles and allow profitability to scale.